Intra-Cellular Therapies rallies as pharma companies buy up smaller rivals
Intra-Cellular Therapies Inc.'s stock was up 35% to $128 a share in premarket trading Monday after Johnson & Johnson said it would buy the mental-health drug maker for nearly $15 billion. J&J is payin ...
S&P 500 on track to erase postelection 'Trump bump'
The S&P 500 opened lower Monday and was on track to wipe out the postelection gain scored following Donald Trump's Nov. 5 victory in the presidential election. The S&P 500 was down around 50 points, ...